Drug Utilization Patterns in Thyroid Disorder Patients with and without Comorbidities: A Cross-Sectional Study in the Outpatient Department of a Tertiary Care Teaching Hospital

Thyroid dysfunction affects approximately 32% of the Indian population, making effective drug utilization crucial for optimal treatment. This study assessed drug utilization patterns in thyroid disorder patients, with and without comorbidities, at a tertiary care hospital. Data from 146 patients’ prescriptions were analyzed based on WHO prescribing indicators and checked for alignment with the National List of Essential Medicines (NLEM) 2022. Results showed 74% of patients had hypothyroidism, predominantly treated with Thyroxine, while 26% had hyperthyroidism, mainly managed with Carbimazole. Hypertension was the most common comorbidity. Findings indicate rational drug use, with most prescriptions aligning with the NLEM, supporting standardized, effective treatment in thyroid disorders.

Authors

Publication Details

Journal
Journal of Internal Medicine and Pharmacology (JIMP)
Published
2024-10-25
DOI
https://doi.org/10.61920/jimp.v1i03.10
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drug Utilization Patterns in Thyroid Disorder Patients with and without Comorbidities: A Cross-Sectional Study in the Outpatient Department of a Tertiary Care Teaching Hospital

Kajal Gupta, Milind L. Pardeshi
Journal of Internal Medicine and Pharmacology (JIMP)
Thyroid Disorders and Treatments
article

Drug Utilization Patterns in Thyroid Disorder Patients with and without Comorbidities: A Cross-Sectional Study in the Outpatient Department of a Tertiary Care Teaching Hospital

Kajal Gupta, Milind L. Pardeshi
article en

Abstract

Thyroid dysfunction affects approximately 32% of the Indian population, making effective drug utilization crucial for optimal treatment. This study assessed drug utilization patterns in thyroid disorder patients, with and without comorbidities, at a tertiary care hospital. Data from 146 patients’ prescriptions were analyzed based on WHO prescribing indicators and checked for alignment with the National List of Essential Medicines (NLEM) 2022. Results showed 74% of patients had hypothyroidism, predominantly treated with Thyroxine, while 26% had hyperthyroidism, mainly managed with Carbimazole. Hypertension was the most common comorbidity. Findings indicate rational drug use, with most prescriptions aligning with the NLEM, supporting standardized, effective treatment in thyroid disorders.

Journal of Internal Medicine and Pharmacology (JIMP)Vol. 1(03)
Good health and well-being
Openalex Percentile: Top 63%
Thyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.